Trabeculectomy Versus Canaloplasty to Treat Glaucoma

Sponsor
University of Cologne (Other)
Overall Status
Unknown status
CT.gov ID
NCT00854256
Collaborator
iScience Interventional Corporation (Industry)
60
1
2
61
1

Study Details

Study Description

Brief Summary

The aim of the study is to investigate pressure lowering effect of two surgical methods canaloplasty and trabeculectomy in patients with open angle glaucoma, in which under local pressure lowering therapy the progression of the disease could not be stopped, and thus a pressure lowering surgical intervention is necessary. The risks in the postoperative course in Canaloplasty in the literature as lower than for the trabeculectomy with mitomycin-C. Conversely, large glaucoma centers questioning the effectiveness of permanent pressure lowering of canaloplasty. Precisely this question is investigated in the study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Canaloplasty
  • Procedure: Trabeculectomy with mitomycin C
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Canaloplasty and Trabeculectomy in Patients With Open Angle Glaucoma and Inadequate Local Eye Pressure Lowering Therapy - a Prospective, Randomized Study
Study Start Date :
Apr 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2013
Anticipated Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Canaloplasty

Procedure: Canaloplasty
Canaloplasty surgery

Active Comparator: Trabeculectomy with mitomycin C

Procedure: Trabeculectomy with mitomycin C
Trabeculectomy with mitomycin C surgery

Outcome Measures

Primary Outcome Measures

  1. Eye pressure [Within 12 month after surgery]

    Eye pressure is measured after 1 month, 2 months, 3 months, 6 months, 9 months, and 12 months after surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with open angle glaucoma and excavation of 0.4 - 0.8

  • 60 eyes of 60 patients (30 patients for trabeculectomy, 30 patients for Canaloplasty) The ratio of female / male is not involved.

  • Eye pressure under local therapy: 20mmHg and above (corrected with pachymetry table).

  • Local drug therapy: at least 2 eye pressure lowering ingredients or absolute intolerance to preservatives or eye drops.

  • general anesthesia possible.

  • The operation must be signed by the surgeon as a state-of-the-art performed without complication to be evaluated. If the operation does not meet this criterion, the patient is excluded from the study.

Exclusion Criteria:
  • all patients are not included in the group of inclusion criteria, or:

  • Phenprocoumon therapy.

  • operation is not done state-of-the-art.

  • after the surgery: additional eye pressure lowering surgery, cataract surgery, keratoplasty, laser surgery in the anterior eye segment (except suture lysis after trabeculectomy)

  • Uveitis, or possible inflammation of the eye

  • Previous eye pressure lowering operations or laser interventions

  • Corneal Refractive Surgery (pseudophakia allowed)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre of Ophthalmology, University of Cologne Cologne NRW Germany 50924

Sponsors and Collaborators

  • University of Cologne
  • iScience Interventional Corporation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00854256
Other Study ID Numbers:
  • iScience-022-CG
First Posted:
Mar 3, 2009
Last Update Posted:
Apr 15, 2013
Last Verified:
Apr 1, 2013
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2013